This post is from a suggested group
Myomectomy Market: Surgical Innovations and Minimally Invasive Gynecology Advancements
The Myomectomy Market—focused on surgical removal of uterine fibroids—is expanding as women seek fertility-preserving alternatives to hysterectomy. Increasing fibroid prevalence among women of reproductive age and advancements in gynecologic surgery are fueling market growth globally.
Market Overview
The myomectomy procedure has evolved with the introduction of laparoscopic, robotic, and hysteroscopic techniques, offering reduced recovery times and enhanced precision. Hospitals and ambulatory surgical centers are adopting these procedures due to lower complication rates and high success in preserving uterine integrity.
Pharmaceutical developments such as gonadotropin-releasing hormone (GnRH) agonists and selective progesterone receptor modulators (SPRMs) also play a role in preoperative fibroid size reduction, improving surgical efficiency.